Microsoft Word - RadBio_Programme_ParisSept2017_verAug31

Previous Page

Next Page

Page Background

Making choices: Therapeutic index

Bcr-abl (Gleevec)

B-raf (PLX4032)

EGFR (Iressa)

PARP/BRCA2

VEGF (Avastin)

Hypoxia tolerance

Oncogene addiction

Synthetic lethality

Contextual synthetic

lethality